Table 3.
Distribution of uncorrected (ng/mL) and specific gravity corrected (italics) urinary analyte concentration in HERMOSA study participants.
| Percentiles | ||||||
|---|---|---|---|---|---|---|
| Metabolite | >LOD (%) | GM | 25% | 50% | 75% | 95% |
| MBzPa | 99.5 | 4.7 | 2.3 | 5.6 | 10.4 | 32.1 |
| 6.6 | 3.8 | 6.4 | 10.6 | 31.3 | ||
| MEHPb | 90.5 | 1.4 | 0.6 | 1.5 | 3.4 | 8.2 |
| 2.0 | 1.0 | 2.1 | 3.4 | 9.0 | ||
| MEHHPb | 98.5 | 4.5 | 2.3 | 5.2 | 9.3 | 21.9 |
| 6.3 | 3.9 | 6.0 | 9.6 | 22.8 | ||
| MECPPb | 99.5 | 8.6 | 4.9 | 9.3 | 18.7 | 36.3 |
| 12.0 | 7.6 | 11.9 | 17.7 | 40.1 | ||
| MEOHPb | 99.0 | 3.6 | 1.9 | 4.0 | 7.7 | 15.9 |
| 5.1 | 3.2 | 4.8 | 7.6 | 16.0 | ||
| ∑DEHP | ----- | ---- | ---- | ---- | ---- | ---- |
| 25.5 | 15.9 | 24.2 | 37.8 | 87.7 | ||
| MCPPc | 98.0 | 1.3 | 0.7 | 1.6 | 2.7 | 6.7 |
| 1.9 | 1.2 | 1.6 | 2.6 | 7.0 | ||
| BPA | 81.5 | 0.8 | 0.3 | 0.9 | 1.9 | 5.9 |
| 1.1 | 0.7 | 1.2 | 2.0 | 5.6 | ||
aMetabolite of BzBP.
bMetabolite of DEHP.
cMetabolite of DOP, DiNP, DiDP.